Plunkett Research Online: Hansa Biopharma AB

HANSA BIOPHARMA AB (HNSA) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Hansa Biopharma AB is a biopharmaceutical company which develops immunomodulatory treatments for enabling transplantations and rare immunoglobulin G (IgG)-mediated autoimmune conditions, transplant rejection and cancer. The company's product candidate, imlifidase, is an antibody-cleaving enzyme bein.....


HANSA BIOPHARMA AB

Ticker: HNSA
Exchange: MEX
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 46 46165670
Fax: 46 46127775
Address: Scheelevagen 22 P.O. Box 785
Lund, 220 07 Sweden

Map
Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
Contacts Description

Hansa Biopharma AB is a biopharmaceutical company which develops immunomodulatory treatments for enabling transplantations and rare immunoglobulin G (IgG)-mediated autoimmune conditions, transplant rejection and cancer. The company's product candidate, imlifidase, is an antibody-cleaving enzyme bein.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture